Bjork Elisabeth — SEC Form 4 filings
SEC reporting owner CIK 1810406. 6 Form 4 filings on record with FilingPulse; latest filed 2026-05-22.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-06-20 to 2026-05-22. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 20,000 shares, $68,500 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 10,000 shares, $293,166 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 6.
- Largest priced transaction: sale of 10,000 shares @ $29.32 ($293,166) in Pharvaris N.V., filed 2026-05-22.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Pharvaris N.V. (PHVS) | Director | 1 | — | 1 leg · 10,000 sh · $293,166 | 2 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | Director | 5 | 2 legs · 20,000 sh · $68,500 | — | 4 |
Form 4 filings — Bjork Elisabeth
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-22 | 4 | Pharvaris N.V. (PHVS) | Option exercise (M): 10,000 @ $8.05 · Sale (S): 10,000 @ $29.32 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Purchase (P): 10,000 @ $3.44 | EDGAR |
| 2025-08-27 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Purchase (P): 10,000 @ $3.41 | EDGAR |
| 2025-07-18 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Grant/award (A): 30,000 @ $0 | EDGAR |
| 2024-10-29 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Grant/award (A): 607 (derivative) @ $0 | EDGAR |
| 2024-06-20 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Grant/award (A): 23,944 (derivative) @ $0 · Grant/award (A): 3,325 (derivative) @ $15.04 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1810406 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →